A NOVEL THERAPEUTIC TARGET FOR MITOCHONDRIAL DYSFUNCTION

A Novel Therapeutic Target for Mitochondrial Dysfunction

Mitochondrial dysfunction plays a wide range of chronic diseases. This deficiency in mitochondrial function can lead to cellular failure, ultimately resulting in diverse pathologies. EPT Fumarate, a novel therapeutic agent, has emerged as a promising treatment for addressing this debilitating issue. EPT Fumarate functions by boosting the activity

read more